| Filed On | Filing |
|---|---|
| 24 Aug 2022 |
8-K/A: Financial Statements and Exhibits
Effective as of August 18, 2022, Precigen, Inc., a Virginia corporation (the “Company”), and its wholly-owned subsidiary, Trans Ova Genetics, L.C., an Iowa limited liability company (“Trans Ova”), completed the previously announced sale ... |
| 06 Feb 2020 | 8-K/A: Financial Statements and Exhibits |
| 01 Jul 2016 | 8-K/A: Entry into a Material Definitive Agreement |
| 03 Nov 2015 | 8-K/A: Financial Statements and Exhibits |
| 28 Oct 2015 | 8-K/A: Financial Statements and Exhibits |
| 28 Jan 2015 | 8-K/A: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 24 Oct 2014 | 8-K/A: Financial Statements and Exhibits |
| 04 Apr 2014 | 8-K/A: Financial Statements and Exhibits |
| 30 Oct 2013 | 8-K/A: Financial Statements and Exhibits |
Loading...
